Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease

Microbial Pathogenesis

Volumn 47, Issue 3, 2009, Pages 151-156

  Meng, Chun ^a   Lin, Haiying ^a   Huang, Jinzhong ^a   Wang, Hang ^a   Cai, Qianyin ^a   Fang, Liang ^a   Guo, Yanghao ^a  

^a FUZHOU UNIVERSITY   (China)

Author keywords

5 Valent conjugate vaccine; Capsular polysaccharides; Pneumococcal surface protein A; Protection; Streptococcus pneumoniae

Indexed keywords

5 VALENT PNEUMOCOCCUS PROTEIN A CAPSULAR POLYSACCHARIDE PNEUMOCOCCUS CONJUGATE VACCINE; BACTERIAL PROTEIN; CHITOSAN; ETHER DERIVATIVE; PLACEBO; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS SURFACE PROTEIN A; PNEUMOCOCCUS VACCINE; POLYCLONAL ANTIBODY; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY AFFINITY; ANTIBODY TITER; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNIZATION; MOLECULAR CLONING; MOUSE; NONHUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PROTECTION; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; SURVIVAL TIME;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL CAPSULES; BACTERIAL PROTEINS; HUMANS; MICE; MICE, INBRED BALB C; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

MUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 68149137902     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2009.05.004     Document Type: Article

References (30)

1. Hausdorff W.P., Feikin D.R., and Klugman K.P. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 5 (2005) 83-93
2. McCullers J.A., and Tuomanen E.I. Molecular pathogenesis of pneumococcal pneumonia. Front Biosci 6 (2001) 877-889
3. Ring A., Weiser J.N., and Tuomanen E.I. Pneumococcal trafficking across the blood-brain barrier. J Clin Invest 102 (1998) 347-360
4. Abraham-Van P.B. Review of pneumococcal conjugate vaccine in adults: implications on clinical development. Vaccine 22 (2004) 1362-1371
5. Paton J.C. New pneumococcal vaccines: basic science developments. In: Tuomanen E.I., Mitchell T.J., Morrison D.A., and Spratt B.G. (Eds). The pneumococcus (2004), ASM Press, Washington, DC 382-402
6. Crain M.J., Waltman W.D., Turner J.S., Yother J., Talkington D.F., McDaniel L.S., et al. Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae. Infect Immun 58 (1990) 3293-3299
7. Yother J., and Briles D.E. Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analysis. J Bacteriol 174 (1992) 601-609
8. Berry A.M., and Paton J.C. Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins. Infect Immun 68 (2000) 133-140
9. Wessels M.R., Paoletti L.C., Kasper D.L., DiFabio J.L., Michon F., Holme K., et al. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus. J Clin Invest 86 (1990) 1428-1433
10. Gor D.O., Ding X., Li Q., Schreiber J.R., Dubinsky M., and Greenspan N.S. Enhanced immunogenicity of pneumococcal surface adhesin a by genetic fusion to cytokines and evaluation of protective immunity in mice. Infect Immun 70 (2002) 5589-5595
11. Sundberg L., and Porath J. Preparation of adsorbents for biospecific affinity chromatography: I attachment of group-containing ligands to insoluble polymers by means of bifunctional oxiranes. J Chromatogr 90 (1974) 87-98
12. Segrest J.P., and Jacksons R.L. Molecular weight measure of glycoproteins by polyacrylamide gel electrophoresis in sodium dodecyl sulfate [A ]Ginsburg VMethods in Enzymology v28B (1972), Academic Press, New York
13. Lin H.Y., Huang J.Z.h., Meng C., and Guo Y.H. Characterization and immunogenicity of the conjugates of capsular polysaccharide outer membrane protein A from pneumococcus type 6. Chin J New Drugs 16 (2007) 2032-2035
14. Dubois M., Gilles K.A., Hamilton J.K., Rebers P.A., and Smith F. Colorimetric method for the determination of sugars and related substances. Anal Chem 28 (1956) 350-356
15. Larson E., Howlett B., and Jagendorf A. Artificial reductant enhancement of the Lowry method for protein determination. Anal Biochem 155 (1986) 243-248
16. Ogunniyi A.D., Grabowicz M., Briles D.E., Cook J., and Paton J.C. Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae. Infect Immun 75 (2007) 350-357
17. Guirola M., Carmenate T., Menendez T., Alvarez A., Gonzalez S., and Guillen G. Comparison of three ELISA protocols to measure antibody responses elicited against serogroup C meningococcal polysaccharide in mouse, monkey and human sera. J Microbiol Methods 65 (2006) 135-143
18. Bobrovnik S.A. Determination of antibody by ELISA theory. J Biochem Biophys Methods 57 (2003) 213-236
19. Tian Y., and Wang Y. A comparison between direct ELISA and national standard method for the detection of Salmonella spp in milk samples. China Dairy Ind 26 (2005) 532-533
20. Cai Q.Y., Fang L., Huang J.Z., Lin H.L., Guo Y.H., and Meng C. Study of expression of pneumococcal surface protein and immunogenicity. China Biotech 28 (2008) 65-69
21. Green B.A., Zhang Y., WMasi A., Barniak V., Wetherell M., and Smith R.P. PppA, a surface-exposed protein of Streptococcus pneumoniae, elicits cross-reactive antibodies that reduce colonization in a murine intranasal immunization and challenge model. Infect Immun 73 (2005) 981-989
22. Berry A.M., and Paton J.C. Sequence heterogeneity of PsaA, a 37-kDa putative adhesin essential for virulence of Streptococcus pneumoniae. Infect Immun 64 (1996) 5255-5262
23. Balachandran P., Brooks-Walter A., Virolainen-Julkunen A., Hollingshead S.K., and Briles D.E. The role of pneumococcal surface protein C (PspC) in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae. Infect Immun 70 (2002) 2526-2534
24. Swiatlo E., and Ware D. Novel vaccine strategies with protein antigens of Streptococcus pneumoniae. FEMS Immunol Med Microbiol 38 (2003) 1-7
25. Orihuela C.J., Gao G., Francis K.P., Yu J., and Tuomanen E.I. Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. J Infect Dis 190 (2004) 1661-1669
26. Palaniappan R., Singh S., Ades E.W., Briles D.E., Hollingshead S.K., Paton J.C., et al. Differential PsaA-, PspA-, PspC, and Pdb-specific immune responses in a mouse model of pneumococcal carriage. Infect Immun 73 (2005) 1006-1013
27. McDaniel L.S., Sheeld J.S., Delucchi P.A., and Briles D.E. PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type. Infect Immun 59 (1991) 222-228
28. Swiatlo E., Brooks-Walter A., Briles D.E., and McDaniel L.S. Oligonucleotides identify conserved and variable regions of pspA and pspA-like sequences of Streptococcus pneumoniae. Gene 188 (1997) 279-284
29. Shapiro E.D., TBerg A., Austrian R., Schroeder D., Parcells V., and Margolis A. Protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 325 (1991) 1453-1460
30. Jackson L.A., Neuzil K.M., Yu O., Benson P., and EBarlow W Adams A.L. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 348 (2003) 1747-1755